Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1992 Jan 11;304(6819):83–87. doi: 10.1136/bmj.304.6819.83

Effect of "fast track" admission for acute myocardial infarction on delay to thrombolysis.

A C Pell 1, H C Miller 1, C E Robertson 1, K A Fox 1
PMCID: PMC1880988  PMID: 1737145

Abstract

OBJECTIVE--To evaluate the impact of a fast track triage system for patients with acute myocardial infarction. DESIGN--Comparison of delays in admission to hospital and in receiving thrombolytic treatment before and after introducing fast track system with delays recorded in 1987-8. Patients fulfilling clinical and electrocardiographic criteria for myocardial infarction were selected for rapid access to the cardiac care team, bypassing evaluation by the medical registrar. SETTING--Major accident and emergency, cardiac and trauma centre. SUBJECTS--359 patients admitted to the cardiac care unit during 1 February to 31 July 1990 with suspected acute infarction. MAIN OUTCOME MEASURES--Accuracy of diagnosis and delay from arrival at hospital to thrombolytic treatment. RESULTS--248 of the 359 patients had myocardial infarction confirmed, of whom 127 received thrombolytic treatment. The fast track system correctly identified 79 out of 127 (62%) patients who subsequently required thrombolytic treatment. 95% (79/83) of patients treated with thrombolysis after fast track admission had the diagnosis confirmed by electrocardiography and enzyme analysis. The median delay from hospital admission to thrombolytic treatment fell from 93 minutes in 1987-8 to 49 minutes in fast track patients (p less than 0.001). Delay in admission to the cardiac care unit was reduced by 47% for fast tract patients (median 60 minutes in 1987-8 v 32 minutes in 1990, p less than 0.001) and by 25% for all patients (60 minutes v 45 minutes, p less than 0.001). CONCLUSION--This fast track system requires no additional staff or equipment, and it halves inhospital delay to thrombolytic treatment without affecting the accuracy of diagnosis among patients requiring thrombolysis.

Full text

PDF
83

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bossaert L. L., Demey H. E., Colemont L. J., Beaucourt L., Fierens H., Dirix L., Pintens H. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Crit Care Med. 1988 Sep;16(9):823–830. doi: 10.1097/00003246-198809000-00001. [DOI] [PubMed] [Google Scholar]
  2. Burns J. M., Hogg K. J., Rae A. P., Hillis W. S., Dunn F. G. Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J. 1989 Apr;61(4):322–325. doi: 10.1136/hrt.61.4.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fox K. A. Thrombolysis and the general practitioner. 1. Practicable only under certain circumstances. BMJ. 1990 Mar 31;300(6728):867–868. doi: 10.1136/bmj.300.6728.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Knabb R. M., Bergmann S. R., Fox K. A., Sobel B. E. The temporal pattern of recovery of myocardial perfusion and metabolism delineated by positron emission tomography after coronary thrombolysis. J Nucl Med. 1987 Oct;28(10):1563–1570. [PubMed] [Google Scholar]
  5. Koren G., Weiss A. T., Hasin Y., Appelbaum D., Welber S., Rozenman Y., Lotan C., Mosseri M., Sapoznikov D., Luria M. H. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985 Nov 28;313(22):1384–1389. doi: 10.1056/NEJM198511283132204. [DOI] [PubMed] [Google Scholar]
  6. MacCallum A. G., Stafford P. J., Jones C., Vincent R., Perez-Avila C., Chamberlain D. A. Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J. 1990 Aug;11 (Suppl F):48–52. doi: 10.1093/eurheartj/11.suppl_f.48. [DOI] [PubMed] [Google Scholar]
  7. Pell A. C., Miller H. C. Delays in admission of patients with acute myocardial infarction to coronary care: implications for thrombolysis. Health Bull (Edinb) 1990 Sep;48(5):225–231. [PubMed] [Google Scholar]
  8. Rawles J. M., Haites N. E. Patient and general practitioner delays in acute myocardial infarction. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):882–884. doi: 10.1136/bmj.296.6626.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Roth A., Barbash G. I., Hod H., Miller H. I., Rath S., Modan M., Har-Zahav Y., Keren G., Bassan S., Kaplinsky E. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol. 1990 Apr;15(5):932–936. doi: 10.1016/0735-1097(90)90219-f. [DOI] [PubMed] [Google Scholar]
  10. Sharkey S. W., Bruneete D. D., Ruiz E., Hession W. T., Wysham D. G., Goldenberg I. F., Hodges M. An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA. 1989 Dec 8;262(22):3171–3174. [PubMed] [Google Scholar]
  11. Sheehan F. H., Mathey D. G., Schofer J., Krebber H. J., Dodge H. T. Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. Am J Cardiol. 1983 Sep 1;52(5):431–438. doi: 10.1016/0002-9149(83)90002-4. [DOI] [PubMed] [Google Scholar]
  12. Van de Werf F., Arnold A. E. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ. 1988 Nov 26;297(6660):1374–1379. doi: 10.1136/bmj.297.6660.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Weaver W. D., Eisenberg M. S., Martin J. S., Litwin P. E., Shaeffer S. M., Ho M. T., Kudenchuk P., Hallstrom A. P., Cerqueira M. D., Copass M. K. Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol. 1990 Apr;15(5):925–931. doi: 10.1016/0735-1097(90)90218-e. [DOI] [PubMed] [Google Scholar]
  14. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES